Stuart Emanuel
30Patents
9h-index
69Co-inventors
78Inventor score
Filing activity: Jun 9, 1997 → Jul 16, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7541367B2 | 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders | Human Necessities | 98 | Active |
| US8343501B2 | Bispecific EGFR/IGFIR binding molecules | Chemistry; Metallurgy | 41 | Active |
| US8524244B2 | Targeted therapeutics based on engineered proteins that bind EGFR | Chemistry; Metallurgy | 40 | Active |
| US9017655B2 | Bispecific EGFR/IGFIR binding molecules | Chemistry; Metallurgy | 34 | Active |
| US9234028B2 | Targeted therapeutics based on engineered proteins that bind EGFR | Chemistry; Metallurgy | 28 | Active |
| US9771411B2 | Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules | Chemistry; Metallurgy | 22 | Active |
| US9920108B2 | Targeted therapeutics based on engineered proteins that bind EGFR | Chemistry; Metallurgy | 19 | Active |
| US6924302B2 | Substituted triazole diamine derivatives as kinase inhibitors | Chemistry; Metallurgy | 12 | Expired |
| US6710048B2 | Pyrazine derivatives as modulators of tyrosine kinases | Chemistry; Metallurgy | 11 | Expired |
| US7855205B2 | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders | Chemistry; Metallurgy | 7 | Active |
| US10183987B2 | Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules | Chemistry; Metallurgy | 7 | Active |
| US10781247B2 | Targeted therapeutics based on engineered proteins that bind EGFR | Chemistry; Metallurgy | 3 | Active |
| US7196110B2 | N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders | Chemistry; Metallurgy | 2 | Expired |
| US7317031B2 | Substituted triazole diamine derivatives as kinase inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US7205298B2 | Substituted triazine kinase inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US8153791B2 | Substituted pyrimidinyl oxime kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US6287853A | Accessory factory function for interferon gamma and its receptor | Chemistry; Metallurgy | 2 | Expired |
| US7888380B2 | 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives | Chemistry; Metallurgy | 1 | Active |
| US10954286B2 | Bispecific EGFR/IGFIR binding molecules | Chemistry; Metallurgy | 1 | Active |
| US8314234B2 | Bicyclic pyrimidine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11021511B2 | Cyclic dinucleotides as sting agonists | Human Necessities | 0 | Active |
| US7427625B2 | Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8367825B2 | Substituted pyrimidinyl oxime kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8299082B2 | 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives | Chemistry; Metallurgy | 0 | Active |
| US7070938B2 | Method to detect modulators of VEGF kinase domain | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.